文献速递糖尿病

数据驱动的2型糖尿病亚组临床特征、并发症与治疗选择的轨迹

Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
PubMed 文献 · Diabetologia · 2024-04-16

研究在荷兰和苏格兰两个初级保健登记队列(N=3054和6145,中位随访11.2和12.3年)中用k-means聚类(基于基线年龄、BMI、HbA1c、HDL-胆固醇和C肽)定义五个亚组,分析危险因素轨迹、并发症时间和用药模式,并与聚类指标直接预测进行比较。亚组分配在随访中总体一致,能捕捉危险因素轨迹、用药模式和并发症风险的显著差异;聚类指标相对亚组是更好的进展变异预测因子,但结合两者可能提高预测准确性。

要点

  • 严重胰岛素抵抗个体发生心肌梗死的风险显著高于轻度糖尿病伴高HDL-胆固醇个体(HR 1.65;95% CI 1.40,1.94)。
  • 严重胰岛素缺乏型糖尿病治疗最强化,诊断后10年超过25%使用胰岛素。
  • 聚类指标相对亚组是更好的进展变异预测因子,但结合两者可能提高预测准确性。

核心结论

  • 数据驱动的亚组分配在随访中总体一致,并捕捉了危险因素轨迹、用药模式和并发症风险的显著差异。
  • 亚组更适合作为补充,而非压缩聚类指标的基础。

研究设计与样本

  • 使用荷兰和苏格兰两个糖尿病队列(N=3054和6145;中位随访分别为11.2年和12.3年)。
  • 通过k-means聚类基于基线年龄、BMI、HbA1c、HDL-胆固醇和C肽定义五个亚组。
  • 分析危险因素轨迹(随机截距模型)、糖尿病相关并发症时间(对数秩检验和Cox模型)和用药模式(多项逻辑回归模型)。
  • 直接比较聚类指标与k-means离散亚组作为进展预测因子。
  • 评估随访期间聚类一致性。

主要发现

  • 亚组间危险因素显著不同,且这些差异在随访中总体保持一致。
  • 与轻度糖尿病伴高HDL-胆固醇相比,严重胰岛素抵抗个体心肌梗死风险显著更高:调整年龄效应前HR 1.65(95% CI 1.40,1.94),调整后HR 1.72(95% CI 1.46,2.02)。
  • 严重胰岛素缺乏型糖尿病治疗最强化,诊断后10年超过25%使用胰岛素。
  • 对于严重胰岛素缺乏型糖尿病相对轻度糖尿病,使用胰岛素相对于无共同治疗的相对风险预计增加3.07倍(95% CI 2.73,3.44),保持其他因素不变。
  • 聚类指标相对亚组是更好的进展变异预测因子,但结合两者可能提高预测准确性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: This study aimed to explore the added value of subgroups that categorise individuals with type 2 diabetes by k-means clustering for two primary care registries (the Netherlands and Scotland), inspired by Ahlqvist's novel diabetes subgroups and previously analysed by Slieker et al. METHODS: We used two Dutch and Scottish diabetes cohorts (N=3054 and 6145; median follow-up=11.2 and 12.3 years, respectively) and defined five subgroups by k-means clustering with age at baseline, BMI, HbA1c, HDL-cholesterol and C-peptide. We investigated differences between subgroups by trajectories of risk factor values (random intercept models), time to diabetes-related complications (logrank tests and Cox models) and medication patterns (multinomial logistic models). We also compared directly using the clustering indicators as predictors of progression vs the k-means discrete subgroups. Cluster consistency over follow-up was assessed. RESULTS: Subgroups' risk factors were significantly different, and these differences remained generally consistent over follow-up. Among all subgroups, individuals with severe insulin resistance faced a significantly higher risk of myocardial infarction both before (HR 1.65; 95% CI 1.40, 1.94) and after adjusting for age effect (HR 1.72; 95% CI 1.46, 2.02) compared with mild diabetes with high HDL-cholesterol. Individuals with severe insulin-deficient diabetes were most intensively treated, with more than 25% prescribed insulin at 10 years of diagnosis. For severe insulin-deficient diabetes relative to mild diabetes, the relative risks for using insulin relative to no common treatment would be expected to increase by a factor of 3.07 (95% CI 2.73, 3.44), holding other factors constant. Clustering indicators were better predictors of progression variation relative to subgroups, but prediction accuracy may improve after combining both. Clusters were consistent over 8 years with an accuracy ranging from 59% to 72%. CONCLUSIONS/INTERPRETATION: Data-driven subgroup allocations were generally consistent over follow-up and captured significant differences in risk factor trajectories, medication patterns and complication risks. Subgroups serve better as a complement rather than as a basis for compressing clustering indicators.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Li X, Donnelly LA, Slieker RC, et al. Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia. 2024. PMID: 38625583. doi:10.1007/s00125-024-06147-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。